Related Experiment Video
Updated: May 10, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
Project HCV Connect: Using a County Surveillance Registry to Link Hepatitis C Virus-Infected Residents to Cure-Los
Chrysovalantis Stafylis1, Cassidy Hernandez-Tamayo, Lokesh Bhardwaj
1Author Affiliations: Keck School of Medicine,Department of Population and Public Health Sciences, University of Southern California, Los Angeles, California (Dr Stafylis, Ms Hernandez-Tamayo, Mr Bhardwaj, Ms Shah, Ms Becerra, Ms Bruce, Ms Saini, Ms Saremi, Mr Thomas, Ms Manansala-Tan, Mr Vij, Ms Li, Mr Sudeep, Mr Gizamba, Mr Hosseini, Ms Navarro, Ms Ufret-Rivera, Dr Gounder, and Dr Klausner); and Los Angeles County Department of Public Health, Acute Communicable Disease Control, Viral Hepatitis Unit, Los Angeles, California (Ms Jewell).
Abstract:
Los Angeles County has a high prevalence of chronic hepatitis C virus (HCV) infection, but resources and infrastructure to notify and increase treatment uptake among county residents are absent. Through an innovative academic-public partnership, we developed a linkage-to-cure program utilizing the Department of Public Health's HCV surveillance registry. Case workers contacted reported cases via phone, to offer education, and treatment referral. Three months after the initial communication, individuals that reported that they were untreated were recontacted to evaluate treatment status. Between April 2023 and March 2024, a total of 639 individuals with HCV were interviewed; 84% of them were aware of their infection status, and 70% were untreated. Among those interviewed three months after initial communication (n = 260), 22% started or completed treatment and 30% were under evaluation for treatment. Leveraging existing resources and new partnerships Public Health Departments could mobilize individuals to seek medical care and lead the effort towards elimination of HCV.
Related Concept Videos
Retrovirus Life Cycles
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction

